COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
AAVantgarde Bio is a Milan-based clinical-stage biotech developing adeno-associated virus (AAV) gene therapies for inherited retinal diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
